Apellis Says Mixed Phase III Results Position Geographic Atrophy Candidate For Filing

 
• By Joseph Haas
  
Eye
Apellis hopes to get the first approval for a geographic atrophy drug
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D